kiirtestid

Kiirtestid are diagnostic tests that provide results quickly, typically within minutes to an hour, to indicate whether a person currently has a specific infection. They are designed for point‑of‑care use and often do not require a full laboratory. In practice the term covers several technologies, most notably rapid antigen tests (lateral flow immunoassays) and rapid molecular tests that use isothermal amplification. Kiirtestid are widely used for screening in healthcare settings, schools, workplaces, travel, and for at‑home testing.

Performance varies by test and by the stage of infection. Rapid antigen tests tend to have high specificity but lower sensitivity than laboratory PCR tests, especially in asymptomatic individuals or early in infection. Rapid molecular tests generally offer higher sensitivity but can be more expensive and less widely available. A positive result on a kiirtest is usually reliable, while a negative result may require confirmation with a laboratory PCR test if symptoms are present, there is known exposure, or guidance from health authorities calls for it. Correct sample collection, proper test procedure, and timely reading are essential to accuracy.

Administration and disposal: tests typically involve a nasal or throat swab, processing steps described in the kit, and reading results within a set time. Used devices and swabs should be disposed of according to local biohazard guidelines.

Regulatory status: rapid tests are regulated in many regions, with CE markings in the European Union and analogous approvals in other countries. Local health authorities provide guidelines on when and how to use kiirtestid, interpretation of results, and follow‑up actions.